High Dose capability for Ypsomed autoinjector platforms

We proudly launch our proven YpsoMate® platform products equipped with the BD Neopak™ XtraFlow™ PFS with 8 mm needle and thin wall cannula. This new cutting-edge solution meets high-dose drug formulation demands by efficiently handling high viscosities and volumes. It highlights the strength of our YpsoMate® range, offering prefilled systems that simplify handling and reduce risks. The new technology expands the possibilities for subcutaneous delivery with handheld autoinjectors, supporting a wide range of therapies. But our commitment to the transition from IV to SC injection goes beyond that: The YpsoDose® patch injector enables large-volume delivery over extended duration in volumes from 2 – 10mL. Our platforms ensure compatibility with existing manufacturing and supply chain processes, enabling fast time-to-market and maintaining robust standards. We strive to widen access to advanced therapies, making self-injection accessible for virtually all patient populations.